4.7 Review

Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 208, Issue 10, Pages 1931-1935

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20111855

Keywords

-

Funding

  1. National Institutes of Health [R01CA133379, R01CA105129, R21CA141399, R01CA149655, R01GM088847]
  2. Leukemia & Lymphoma Society
  3. American Cancer Society [RSG0806801]
  4. Irma T. Hirschl Trust
  5. Chemotherapy Foundation
  6. V Foundation for Cancer Research
  7. Helen and Martin Kimmel Center for Stem Cell Biology at NYU

Ask authors/readers for more resources

Notch signaling is often considered a model hematopoietic proto-oncogene because of its role as the main trigger of T cell acute lymphoblastic leukemia (T-ALL). Although its role in T-ALL is well characterized and further supported by a high frequency of activating NOTCH1 mutations in T-ALL patients, it still remains an open question whether the effects of Notch signaling are causative in other types of cancer, including solid tumors. Growing evidence supported by recent studies unexpectedly shows that Notch signaling can also have a potent tumor suppressor function in both solid tumors and hematological malignancies. We discuss the intriguing possibility that the pleiotropic functions of Notch can be tumor suppressive or oncogenic depending on the cellular context.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available